Logo image
Back
Inhibition of the promotion of hepatocarcinogenesis by 2,2',4,4',5,5'-hexachlorobiphenyl (PCB-153) by the deletion of the p50 subunit of NF-kappa B in mice
Journal article   Open access   Peer reviewed

Inhibition of the promotion of hepatocarcinogenesis by 2,2',4,4',5,5'-hexachlorobiphenyl (PCB-153) by the deletion of the p50 subunit of NF-kappa B in mice

Howard P Glauert, Job C Tharappel, Subhashis Banerjee, Nelson L S Chan, Izabela Kania-Korwel, Hans-Joachim Lehmler, Eun Y Lee, Larry W Robertson and Brett T Spear
Toxicology and applied pharmacology, Vol.232(2), pp.302-308
10/15/2008
DOI: 10.1016/j.taap.2008.06.013
PMCID: PMC2583134
PMID: 18644402
url
https://doi.org/10.1016/j.taap.2008.06.013View
Published (Version of record) Open Access

Abstract

Polychlorinated biphenyls (PCBs) are persistent and ubiquitous environmental chemicals that bioaccumulate and have hepatic tumor promoting activity in rodents. The present study examined the effect of deleting the p50 subunit of NF-kappaB on the hepatic tumor promoting activity of 2,2',4,4',5,5'-hexachlorobiphenyl (PCB-153) in mice. Both wild-type and p50-/- male mice were injected i.p. with diethylnitrosamine (DEN, 90 mg/kg) and then subsequently injected biweekly with 20 i.p. injections of PCB-153 (300 micromol/kg/injection). p50 deletion decreased the tumor incidence in both PCB- and vehicle-treated mice, whereas PCB-153 slightly (P=0.09) increased the tumor incidence in wild-type and p50-/- mice. PCB-153 increased the total tumor volume in both wild-type and p50-/- mice, but the total tumor volume was not affected by p50 deletion in either PCB- or vehicle-treated mice. The volume of tumors that were positive for glutamine synthetase (GS), which is indicative of mutations in the beta-catenin gene, was increased in both wild-type and p50-/- mice administered PCB-153 compared to vehicle controls, and inhibited in p50-/- mice compared to wild-type mice (in both PCB- and vehicle-treated mice). The volume of tumors that were negative for GS was increased in p50-/- mice compared to wild-type mice but was not affected by PCB-153. PCB-153 increased cell proliferation in normal hepatocytes in wild-type but not p50-/- mice; this increase was inhibited in p50-/- mice. In hepatic tumors, the rate of cell proliferation was much higher than in normal hepatocytes, but was not affected by PCB treatment or p50 deletion. The rate of apoptosis, as measured by the TUNEL assay, was not affected by PCB-153 or p50 deletion in normal hepatocytes. In hepatic tumors, the rate of apoptosis was lower than in normal hepatocytes; PCB-153 slightly (P=0.10) increased apoptosis in p50-/- but not wild-type mice; p50 deletion had no effect. Taken together, these data indicate that the absence of the NF-kappaB p50 subunit inhibits the promoting activity of PCB-153 and alters the proliferative and apoptotic changes in mouse liver in the response to PCBs.
 Liver Neoplasms - prevention & control Liver Neoplasms - genetics Apoptosis - drug effects Liver Neoplasms - chemically induced Apoptosis - genetics Male Polychlorinated Biphenyls - antagonists & inhibitors NF-kappa B p50 Subunit - genetics NF-kappa B p50 Subunit - deficiency Carcinogens - toxicity Mice, Knockout Animals Carcinogens - antagonists & inhibitors Polychlorinated Biphenyls - toxicity Gene Deletion Liver Neoplasms - metabolism Mice NF-kappa B p50 Subunit - physiology

Details

Metrics

20 Record Views
21 Times Cited - Web of Science
Logo image